Flyer for Pemphigus Foliaceus Clinical Trial in Dogs

Select for Larger Image

Below, please find links to all of the clinical trials involving dermatology. The studies include a multitude of information, including (but not limited to) the study’s purpose, benefits for participating, and financial incentive information. If you have any questions, please contact the individual outlined at the end of each trial summary.

Please visit the Dermatology service webpage at the Veterinary Medical Teaching Hospital (VMTH) if you would like to learn more about the amazing things that our veterinarians can do for you and your animal.

On Hold Until Further Notice

Pemphigus Foliaceus: Finding a New Treatment in Dogs

Title: A Pilot Study of the Efficacy of a Bruton’s Tyrosine Kinase Inhibitor (BTKi) in the Treatment of Dogs with Pemphigus Foliaceus (PF)

Purpose of Study: Although it is a rare skin disease, pemphigus foliaceus (PF) is the most common form of pemphigus and probably the most common cutaneous autoimmune disease in the dog. The goal of this study is to assess the efficacy of a Bruton’s Tyrosine Kinase inhibitor (BTKi) as a therapy for canine pemphigus foliaceus (as pills which can also be crushed into powder in food if necessary).

If you cannot find what you are looking for, please email us or call (530) 752-5366.